BioCentury
ARTICLE | Company News

J&J partners with Wellcome Trust, KU Leuven for dengue

August 30, 2013 11:58 PM UTC

The Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson (NYSE:JNJ) partnered with the Wellcome Trust and the Catholic University of Leuven (KU Leuven) to discover and develop antivirals to tr...